Search

You searched for "bionic"

67 results found

Simon Lysaght joins Glaukos as Territory Manager, Ireland

28 June 2023 | Recruitment & Personnel
Glaukos Corporation is delighted to announce the appointment of Simon Lysaght to the position of Territory Manager, Ireland.

RNIB makes sound decision to create memorable new sonic logo

6 December 2023 | RNIB, Sonic, Branding, sight loss, sight impairment, blind
Leading sight loss charity RNIB (Royal National Institute of Blind People) turned to blind and partially sighted people to help create a new sonic identity for the charity.

Why Ophthalmology?

13 December 2023 | | EYE - General
Ophthalmology is a medical specialty that deals with eye diseases and helps preserve vision. The ophthalmic community consists of a wide range of healthcare professionals who work together to address eye-related problems in many extraordinary ways. This article explores the...

Dolby’s Sound of a Masterpiece: Hear what Da Vinci's Mona Lisa and Monet's Water-Lily Pond sound like

9 April 2025 | RNIB, immersive experience, blindness, partially sighted, art, Dolby Laboratories, patient stories
Dolby Laboratories and Royal National Institute of Blind People (RNIB) have reimagined the world’s most famous artwork masterpieces - from Da Vinci’s Mona Lisa to David Hockney’s A Bigger Splash - to create an immersive soundtrack, in state-of-the-art Dolby Atmos...

Twenty-five years in retina

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...

Effects of phacoemulsification on IOP and drug use in glaucoma

1 December 2017 | | EYE - Glaucoma
For patients with comorbid cataract and primary open-angle glaucoma (POAG), guidance is lacking as to whether cataract extraction and traditional filtering surgery should be performed as a staged or combined procedure. Achieving this guidance requires an evidence-based understanding of the...

The assessment of pupils and 
pupillary reactions

1 October 2015 | | EYE - Vitreo-Retinal
Understanding pupillary reactions is vital in understanding basic neuro-opthalmology. It is a skill required in eye casualty, clinics and perhaps most importantly, exams. To start at the beginning, the pupil is the central aperture of the iris, its size controlling...

OBITUARY: A short tribute to Mike Sanders, Neuro-ophthalmologist

3 October 2022 | | EYE - Neuro-ophthalmology
Mike Sanders was Consultant Neuro-Ophthalmologist at St Thomas’ Hospital and the National Hospital, Queen Square in London, 1969 to 1999. He passed away on 25 July of this year. Over this 30-year period he had huge influence over the evolution...

How to diagnose and treat Acanthamoeba keratitis

1 February 2019 | | EYE - Cornea, EYE - General
Corneal ulceration caused by Acanthamoeba is on the rise, and recent publications indicate an outbreak in the UK over the last few years [1]. Since Acanthamoeba keratitis often presents with atypical features, diagnosis from slit-lamp examination alone can often be...

Advances in cataract surgery

1 April 2018 | | EYE - Cataract, EYE - Refractive
This article covers recent clinical findings in mydriasis and anaesthesia for cataract surgery, shared by Sathish Srinivasan and Keith Davey at a surgical meeting in Manchester. Towards dropless cataract surgery Day case cataract surgery is the standard of care in...

NICE drugs: an update on what’s good to go

1 June 2014 | | EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...

Update on emerging therapies for age-related macular degeneration

4 December 2023 | | EYE - Vitreo-Retinal
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...